Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/05/14 → 30/04/17 |
Funding
- Cancer Australia: A$452,383.00
An inhalable dendrimer-based delivery platform for the targeted treatment of primary and secondary lung cancers
- Kaminskas, Lisa (Primary Chief Investigator (PCI))
- Porter, Christopher (Chief Investigator (CI))
Project: Research